NCT02049905 2024-06-13Phase 3 Study to Treat Patients With Soft Tissue SarcomasImmunityBio, Inc.Phase 3 Completed433 enrolled 10 charts
NCT00334282 2016-02-05Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell CarcinomaGlaxoSmithKlinePhase 3 Completed435 enrolled 19 charts